Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
Thursday, August 28, 2025Heidelberg Pharma AG a clinical stage biotech company developing innovative Antibody Drug Conjugates ADCs today announced that its licensing partner Telix Pharmaceuticals Limited headquartered in Melbourne Australia
Leqembi® (lecanemab) launched in the EU today
Tuesday, August 26, 2025BioArctic ABs publ NASDAQ Stockholm BIOA B partner Eisai announced today that the launch of Leqembi in the EU started in Austria on August and will be launched in Germany on September
VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease
Friday, August 22, 2025VeonGen Therapeutics a clinicalstage genetic medicine company developing nextgeneration gene therapies today announced that the US Food and Drug Administration FDA has granted Regenerative Medicine Advanced Therapy
EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension
Thursday, August 21, 2025Regeneron Pharmaceuticals Inctoday announced that the US Food and Drug Administration FDA has extended the target action dates to the fourth quarter of for two EYLEA HD aflibercept Injection
Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease
Thursday, August 21, 2025Rocket Pharmaceuticals Inca fully integrated latestage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need today announced that the US Food and Drug Administration
Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries
Wednesday, August 20, 2025Santhera Pharmaceuticalsannounces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE vamorolone in the United Arab Emirates the Kingdom of Saudi Arabia Kuwait
Aldeyra Therapeutics Receives Fast Track Designation for ADX‑2191 for the Treatment of Retinitis Pigmentosa
Wednesday, August 20, 2025Aldeyra Therapeutics Inctoday announced that the US Food and Drug Administration FDA has granted fast track designation for ADX methotrexate intravitreal injection USP for the treatment of retinitis pigmentosa
Upperton Pharma Solutions Awarded VaxHub Sustainable Grant to Advance Oral Vaccine Delivery in Partnership with the University of Oxford’s Pandemic Sciences Institute.
Tuesday, August 19, 2025Upperton Pharma Solutions a leading UKbased contract development and manufacturing organisation CDMO has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call
Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
Tuesday, August 19, 2025Tonix Pharmaceuticals Holding Corp Nasdaq TNXP a fullyintegrated biotechnology company today announced that the US Food and Drug Administration FDA approved Tonmya cyclobenzaprine HCl sublingual tablets for the treatment of fibromyalgia in adults Ton...
Clarivate Launches AI-powered Regulatory Assistant Within Cortellis Suite to Boost Productivity and Ease Regulatory Burden
Saturday, August 16, 2025Clarivate Plca leading global provider of transformative intelligence today announced the beta launch of its AIpowered Regulatory Assistant within Cortellis Regulatory Intelligence This new capability is designed to help regulatory professionals navi...
